Cargando…

Hypoalbuminaemia – A Marker of Cardiovascular Disease in Patients with Chronic Kidney Disease Stages II - IV

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD) patients. Serum albumin, a negative acute-phase reactant and marker for underlying inflammation and/or malnutrition, is an independent predictor of CVD and mortality in CKD VI patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Nehal Rachit, Dumler, Francis
Formato:	Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2008
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583337/ https://www.ncbi.nlm.nih.gov/pubmed/19015744

Ejemplares similares

Oedema in kwashiorkor is caused by hypoalbuminaemia
por: G. Coulthard, Malcolm
Publicado: (2015)

Hypoalbuminaemia predicts outcome in adult patients with congenital heart disease
por: Kempny, Aleksander, et al.
Publicado: (2015)

Remdesivir: Hypotension and hypoalbuminaemia: 2 case reports
Publicado: (2022)

Serum Cystatin C – Marker of Inflammation and Cardiovascular Morbidity in Chronic Kidney Disease Stages 1-4
por: Muslimovic, Alma, et al.
Publicado: (2015)

Hypoalbuminaemia in haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital
por: Machingura, Pasipanodya Ian, et al.
Publicado: (2015)

Retinal and choroidal thickness in paediatric patients with hypoalbuminaemia caused by nephrotic syndrome
por: Zhang, Wenbo, et al.
Publicado: (2019)

Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
por: Sinha, Sanjay, et al.
Publicado: (2022)

Increased Prevalence and Severity of Coronary Artery Calcification in Patients with Chronic Kidney Disease Stage III and IV
por: Koukoulaki, Maria, et al.
Publicado: (2012)

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
por: Forns, Xavier, et al.
Publicado: (2015)

Preoperative hypoalbuminaemia in liver surgery: an observational study at a university medical centre
por: Kuhlmann, Anna Dorothea, et al.
Publicado: (2023)

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
por: Marques, Gustavo Lenci, et al.
Publicado: (2021)

Hypoalbuminaemia and One-Year Mortality in Haemodialysis Patients with Heart Failure: A Cohort Analysis
por: Cardoso, Ana, et al.
Publicado: (2021)

Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada
por: Ravani, Pietro, et al.
Publicado: (2020)

Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4
por: Kiu Weber, Chek Ing, et al.
Publicado: (2014)

The Correlation between Preoperative and Postoperative Hypoalbuminaemia and the Development of Acute Kidney Injury with Respect to the KDIGO Criteria in the Hip Fracture Surgery in Elderly Patients
por: Küpeli, İlke, et al.
Publicado: (2020)

The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases
por: Al-Shaiba, R, et al.
Publicado: (2004)

Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders
por: Magnussen, Bjarne, et al.
Publicado: (2016)

Early Postoperative Hypoalbuminaemia as a Risk Factor for Postoperative Pneumonia Following Hip Fracture Surgery
por: Shin, Kyun-Ho, et al.
Publicado: (2020)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

The effect of Fasting during Ramadan on the Kidney functions of Stage III-IV Chronic Kidney Disease Patients
por: Karatas, Ahmet, et al.
Publicado: (2021)

In vivo evaluation of an innovative synbiotics on stage IIIb-IV chronic kidney disease patients
por: Vacca, Mirco, et al.
Publicado: (2023)

PERIODONTAL DISEASE IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE
por: Kopić, Vlatko, et al.
Publicado: (2019)

Haptoglobin Genotype and Risk Markers of Cardiovascular Disease in Patients with Chronic Kidney Disease
por: Strandhave, Charlotte, et al.
Publicado: (2013)

Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
por: Vallianou, Natalia G., et al.
Publicado: (2019)

Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction
por: Sulemane, Samir, et al.
Publicado: (2017)

Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis
por: Chandrasinghe, Pramodh C, et al.
Publicado: (2013)

Depression and incident cardiovascular disease among patients with chronic kidney disease
por: D'Oro, Anthony, et al.
Publicado: (2023)

Stage II of Chronic Kidney Disease—A Tipping Point in Disease Progression?
por: Grgurevic, Lovorka, et al.
Publicado: (2022)

Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
por: Borg, Rikke, et al.
Publicado: (2023)

Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II–IV rectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
por: Căpuşă, Cristina, et al.
Publicado: (2017)

Sarcopenia predicts cardiovascular disease in chronic kidney disease at advanced stage and associated risks
por: Xuan, Yingli, et al.
Publicado: (2023)

Synergistic effect of hypoalbuminaemia and hypotension in predicting in-hospital mortality and intensive care admission: a retrospective cohort study
por: Klang, Eyal, et al.
Publicado: (2021)

Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer
por: Stares, Mark, et al.
Publicado: (2021)

Studies on the Relation of the Kidney to Cardiovascular Disease: IV. Tolerance and the Pressor Agent of Kidney Extracts
por: Winternitz, M. C., et al.
Publicado: (1941)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
por: Alshurafa, Awni, et al.
Publicado: (2022)

The cardiovascular determinants of physical function in patients with end-stage kidney disease on haemodialysis
por: Adenwalla, Sherna F., et al.
Publicado: (2020)

Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease
por: Makulska, Irena, et al.
Publicado: (2012)

Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease
por: Stopic, Bojan, et al.
Publicado: (2022)

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
por: Kent, Seamus, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_69mk3tkgus8bcned23tf3u9eot